BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 9747832)

  • 1. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protracted radiotherapy treatment duration in medulloblastoma.
    Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
    Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma in adults: treatment results and prognostic factors.
    Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult medulloblastoma: prognostic factors and patterns of relapse.
    Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
    Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results for 149 medulloblastoma patients from one institution.
    Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose craniospinal radiation therapy for medulloblastoma.
    Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.
    Sun LM; Yeh SA; Wang CJ; Huang EY; Chen HC; Hsu HC; Lee SP
    J Neurooncol; 2002 May; 58(1):77-85. PubMed ID: 12160144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
    Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
    Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
    Liu Y; Zhu Y; Gao L; Xu G; Yi J; Liu X; Li Y
    Jpn J Clin Oncol; 2005 Mar; 35(3):111-5. PubMed ID: 15741299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
    Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniospinal radiotherapy in adult medulloblastoma.
    Selek U; Zorlu F; Hurmuz P; Cengiz M; Turker A; Soylemezoglu F; Gurkaynak M
    Strahlenther Onkol; 2007 May; 183(5):236-40. PubMed ID: 17497094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy.
    Wara WM; Le QT; Sneed PK; Larson DA; Prados MD; Levin VA; Edwards MS; Weil MD
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):551-6. PubMed ID: 7928485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of radiation therapy for medulloblastoma].
    Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
    Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
    Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.